⌕
Adaptive Biotechnologies · ADPT · Nasdaq
Tenet 43 · Weak
Compare
$29.04−1.49%At closeTenet 43 · Weak
$29.04−0.44 (−1.49%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Adaptive Biotechnologies (ADPT) Stock

Adaptive Biotechnologies (ADPT) closed at $29.04 on Nov 13, 2026; its Tenet Score is 43 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

19 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$29.04
Nov 13, 2026
Market cap
$4.7B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
12.00 – 32.21
low → high
Tenet Score
43/100
Weak · 409 Healthcare peers

Industry: Health Services · see every company filed here →

Adaptive Biotechnologies Corp scores 43/100. Weak. Strongest on financial health, value is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
43/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
6
Quality
44
Health
69
Growth
52

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityDHealthCGrowthCMomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
loss
P/B
26.7×
price to book value
P/S
15.8×
price to fiscal 2025 sales
ROE
−36%
return on equity
Operating margin
−20.6%
fiscal 2025, before interest and tax
Net margin
−23.7%
of revenue kept
Current ratio
3.97
current assets to liabilities
Net debt / EBITDA
—
no_ebitda
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer tra…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 79 US ETFs · top wrappers by weightSee all ETFs holding ADPT →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Adaptive Biotechnologies in?

Adaptive Biotechnologies is in the Healthcare sector and the Health Services industry.

What is Adaptive Biotechnologies' Tenet Score?

Adaptive Biotechnologies' Tenet Score is 43 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.